Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.

On Friday, the Biden administration announced that the trio of weight loss drugs top the list of prescription drugs ... they account for a third of all Part D spending, according to CMS.

He notes the need for an “all-hands-on-deck approach” with ... chief medical officer at the medically-assisted weight loss program, Found, and practicing endocrinologist in New York City.

Jack & Jill provides a doctor-led, subscription-based weight loss program tailored for adults ... However, it’s not all good news. A customer shared their frustrating experience with the company ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for ... to ensure access and affordability for all patients." The pharmaceutical industry's legal ...

WHAT IT MEANS FOR PATIENTSThe potential for more aggressive price cuts would enable wider access to GLP-1 drugs - the same ...

This guide highlights what employers and benefits advisors should watch for in weight-management programs ... loss medications — and not just the ones in the headlines. There is no one-size-fits ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...